↓ Skip to main content

Cochrane Database of Systematic Reviews

Dopamine agents for hepatic encephalopathy

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter
peer_reviews
1 peer review site

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
79 Mendeley
Title
Dopamine agents for hepatic encephalopathy
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd003047.pub3
Pubmed ID
Authors

Anders Ellekaer Junker, Bodil Als-Nielsen, Christian Gluud, Lise Lotte Gluud

Abstract

Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 19%
Student > Bachelor 14 18%
Student > Ph. D. Student 9 11%
Other 7 9%
Student > Postgraduate 7 9%
Other 14 18%
Unknown 13 16%
Readers by discipline Count As %
Medicine and Dentistry 33 42%
Psychology 5 6%
Unspecified 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Nursing and Health Professions 4 5%
Other 10 13%
Unknown 17 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2020.
All research outputs
#10,407,607
of 17,405,806 outputs
Outputs from Cochrane database of systematic reviews
#9,630
of 11,674 outputs
Outputs of similar age
#95,347
of 200,033 outputs
Outputs of similar age from Cochrane database of systematic reviews
#190
of 215 outputs
Altmetric has tracked 17,405,806 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,674 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.1. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,033 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 215 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.